药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Loteprednol etabonate
Buformin
The therapeutic efficacy of Buformin can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
AICA ribonucleotide
The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Glymidine
The therapeutic efficacy of Glymidine can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Insulin glulisine
The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Insulin detemir
The therapeutic efficacy of Insulin detemir can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Insulin aspart
The therapeutic efficacy of Insulin aspart can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Glisoxepide
The therapeutic efficacy of Glisoxepide can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Pramlintide
The therapeutic efficacy of Pramlintide can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Mecasermin
The therapeutic efficacy of Mecasermin can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Exenatide
The therapeutic efficacy of Exenatide can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Mitiglinide
The therapeutic efficacy of Mitiglinide can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Gliquidone
The therapeutic efficacy of Gliquidone can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Gliclazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Lumefantrine
The serum concentration of Lumefantrine can be decreased when it is combined with St. John's Wort.
Loteprednol etabonate
Artemether
The serum concentration of dihydroartemisinin, an active metabolite of Artemether, can be decreased when used in combination with St. John's Wort.
Loteprednol etabonate
Daclatasvir
The serum concentration of Daclatasvir can be decreased when it is combined with St. John's Wort.
Loteprednol etabonate
Cobicistat
The serum concentration of Cobicistat can be decreased when it is combined with St. John's Wort.
Loteprednol etabonate
Lurasidone
The serum concentration of Lurasidone can be decreased when it is combined with St. John's Wort.
Loteprednol etabonate
Isavuconazonium
The serum concentration of Isavuconazonium can be decreased when it is combined with St. John's Wort.
Loteprednol etabonate
Telaprevir
The serum concentration of Telaprevir can be decreased when it is combined with St. John's Wort.